- Drug delivery devices manufacturer AptarGroup Inc (NYSE:ATR) is collaborating with YAT, a Chinese Online Skincare Company, to develop a range of products and services for the skincare market.
- The partnership will combine YAT’s product design and concept development capabilities and Aptar’s packaging and dispensing solutions.
- The financial terms of the deal were not disclosed.
- Aptar will use YAT’s market insight database, focused on specific consumer skincare needs and skincare profiles.
- “Aptar’s breadth of experience in manufacturing high-quality solutions, including innovative solutions that contribute to a more circular economy, combined with YAT’s extensive market insights, will enhance the growing portfolio of solutions and services we can bring to this market,” said CEO Stephan Tanda.
- Price action: ATR shares closed lower by 1.24% at $139.27 on Thursday.
HC Wainwright & Co. Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $64
HC Wainwright & Co. analyst Ed Arce maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and raises the price target from $51 to $64.
